EAM Investors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $578K | Buy |
+254,580
| New | +$578K | 0.09% | 205 |
|
|
2018
Q2 | – | Sell |
-42,990
| Closed | -$1.22M | – | 301 |
|
|
2018
Q1 | $1.22M | Buy |
+42,990
| New | +$1.22M | 0.2% | 180 |
|
|
2016
Q2 | – | Sell |
-45,784
| Closed | -$591K | – | 313 |
|
|
2016
Q1 | $591K | Buy |
45,784
+10,928
| +31% | +$141K | 0.09% | 293 |
|
|
2015
Q4 | $727K | Buy |
+34,856
| New | +$727K | 0.1% | 299 |
|